Valuation : PERRIGO

Market Cap 2.07B 1.78B 1.67B 1.53B 2.86B 196B 2.87B 19.86B 7.68B 100B 7.78B 7.61B 319B P/E 2026 *
1,492x
P/E 2027 * 12.4x
Enterprise Value 4.98B 4.28B 4.02B 3.67B 6.87B 471B 6.89B 47.71B 18.44B 241B 18.68B 18.27B 767B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.19x
Free-Float
99.6%
Yield 2026 *
7.75%
Yield 2027 * 7.95%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-0.95%+0.23%+30.91%+37.78% 352B
-3.18%+1.78%+22.62%+41.55% 304B
+0.30%+0.67%+0.60%+11.25% 252B
-1.55%+1.11%+54.15%+75.59% 236B
+0.02%+2.24%-13.83%-55.80% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.98%+1.26%+28.74%+52.15% 408.71B
Weighted average by Cap. -1.04%+0.62%+37.66%+66.90%

Financials

2026 *2027 *
Net sales 4.06B 3.49B 3.28B 3B 5.61B 384B 5.62B 38.93B 15.05B 197B 15.24B 14.91B 626B 4.09B 3.52B 3.31B 3.02B 5.65B 387B 5.67B 39.22B 15.16B 198B 15.36B 15.02B 631B
Net income -224M -193M -181M -165M -309M -21.19B -310M -2.15B -831M -10.85B -842M -823M -34.57B -56.95M -48.98M -46.06M -42.05M -78.64M -5.39B -78.9M -546M -211M -2.76B -214M -209M -8.79B
Net Debt 2.9B 2.5B 2.35B 2.14B 4.01B 275B 4.02B 27.86B 10.77B 141B 10.91B 10.67B 448B 2.78B 2.39B 2.25B 2.06B 3.84B 263B 3.86B 26.7B 10.32B 135B 10.45B 10.23B 429B
Logo PERRIGO
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!